A. Ruol

4.6k total citations · 2 hit papers
67 papers, 3.6k citations indexed

About

A. Ruol is a scholar working on Hepatology, Epidemiology and Pharmacology. According to data from OpenAlex, A. Ruol has authored 67 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Hepatology, 45 papers in Epidemiology and 5 papers in Pharmacology. Recurrent topics in A. Ruol's work include Liver Disease Diagnosis and Treatment (34 papers), Hepatitis C virus research (28 papers) and Hepatitis B Virus Studies (24 papers). A. Ruol is often cited by papers focused on Liver Disease Diagnosis and Treatment (34 papers), Hepatitis C virus research (28 papers) and Hepatitis B Virus Studies (24 papers). A. Ruol collaborates with scholars based in Italy, Netherlands and Switzerland. A. Ruol's co-authors include A. Albertí, G. Giustina, Giovanna Fattovich, G. Realdi, Patrizia Pontisso, S. Favarato, F. Tremolada, Massimo Rugge, L. Brollo and A Rigoli and has published in prestigious journals such as The Lancet, Blood and Annals of Internal Medicine.

In The Last Decade

A. Ruol

65 papers receiving 3.4k citations

Hit Papers

Comparison of subcutaneou... 1980 2026 1995 2010 1992 1980 100 200 300 400

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
A. Ruol 2.6k 2.5k 456 387 379 67 3.6k
Dominique Roulot 3.6k 1.4× 3.6k 1.4× 37 0.1× 825 2.1× 142 0.4× 112 4.9k
Susan L. Orloff 966 0.4× 1.5k 0.6× 45 0.1× 967 2.5× 88 0.2× 118 2.7k
Howard F. Taswell 1.4k 0.5× 1.2k 0.5× 25 0.1× 727 1.9× 84 0.2× 105 3.4k
Jérôme Le Pavec 418 0.2× 527 0.2× 114 0.3× 843 2.2× 833 2.2× 112 4.3k
J P Benhamou 701 0.3× 491 0.2× 53 0.1× 477 1.2× 33 0.1× 61 1.4k
Paul McMaster 2.4k 0.9× 1.3k 0.5× 44 0.1× 2.2k 5.8× 30 0.1× 75 3.4k
PM Mannucci 275 0.1× 467 0.2× 545 1.2× 701 1.8× 648 1.7× 116 4.2k
Pearl Toy 210 0.1× 591 0.2× 155 0.3× 391 1.0× 213 0.6× 93 4.2k
Simone Saibeni 144 0.1× 809 0.3× 198 0.4× 850 2.2× 65 0.2× 99 2.3k
Christophe Bureau 4.5k 1.8× 3.8k 1.5× 29 0.1× 2.6k 6.8× 82 0.2× 141 5.4k

Countries citing papers authored by A. Ruol

Since Specialization
Citations

This map shows the geographic impact of A. Ruol's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Ruol with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Ruol more than expected).

Fields of papers citing papers by A. Ruol

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Ruol. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Ruol. The network helps show where A. Ruol may publish in the future.

Co-authorship network of co-authors of A. Ruol

This figure shows the co-authorship network connecting the top 25 collaborators of A. Ruol. A scholar is included among the top collaborators of A. Ruol based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Ruol. A. Ruol is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fattovich, Giovanna, G. Giustina, S. Favarato, & A. Ruol. (1996). A survey of adverse events in 11 241 patients with chronic viral hepatitis treated with alfa interferon. Journal of Hepatology. 24(1). 38–47. 379 indexed citations
2.
Giustina, G., Giovanna Fattovich, Massimo De Paoli, et al.. (1996). Serum procollagen type III peptide in chronic hepatitis B. International Journal of Clinical & Laboratory Research. 26(1). 33–36. 12 indexed citations
3.
Caregaro, Lorenza, Angelo Gatta, Piero Amodio, et al.. (1994). Juxtaglomerular Cell Tumor of the Kidney. Clinical and Experimental Hypertension. 16(1). 41–53. 11 indexed citations
4.
Diodati, G., C. Casarin, Sergio Scaccabarozzi, et al.. (1994). Interferon antibodies in patients with chronic hepatitic C virus infection treated with recombinant interferon alpha-2α. Journal of Hepatology. 20(3). 416–420. 42 indexed citations
5.
Fattovich, Giovanna, G. Giustina, A. Albertí, et al.. (1994). A randomized controlled trial of thymopentin therapy in patients with chronic hepatitis B. Journal of Hepatology. 21(3). 361–366. 11 indexed citations
6.
Diodati, G., Paola Bonetti, A. Tagger, et al.. (1994). Relationship between serum HCV markers and response to interferon therapy in chronic hepatitis C. Digestive Diseases and Sciences. 39(11). 2497–2502. 18 indexed citations
7.
Fattovich, Giovanna, Patrizia Farci, Massimo Rugge, et al.. (1992). A Randomized Controlled Trial of Lymphoblastoid Interferon–α in Patients With Chronic Hepatitis B Lacking Hbeag. Hepatology. 15(4). 584–589. 125 indexed citations
8.
Benvegnù, Luisa, A. Cecchetto, F. Noventa, et al.. (1992). Space‐occupying lesions of the liver detected by ultrasonography and their relation to hepatocellular carcinoma in cirrhosis. Liver International. 12(2). 80–83. 2 indexed citations
9.
Fattovich, Giovanna, L. Brollo, G. Giustina, et al.. (1991). Natural history and prognostic factors for chronic hepatitis type B.. Gut. 32(3). 294–298. 330 indexed citations
10.
Albertí, A., A. Tagger, Antonio Dal Canton, et al.. (1991). Antibody to Hepatitis C Virus and Liver Disease in Volunteer Blood Donors. Annals of Internal Medicine. 114(12). 1010–1012. 64 indexed citations
11.
Diodati, G., A. Tagger, Paola Bonetti, et al.. (1991). Antibody to hepatitis C virus in cryptogenic chronic liver disease. Journal of Medical Virology. 35(3). 151–154. 12 indexed citations
12.
Amodio, Piero, et al.. (1991). Theophylline Pharmacokinetics and Liver Function Indexes in Chronic Liver Disease. Respiration. 58(2). 106–111. 10 indexed citations
13.
Merkel, Carlo, Angelo Gatta, Marco Zoli, et al.. (1991). Prognostic value of galactose elimination capacity, aminopyrine breath test, and ICG clearance in patients with cirrhosis. Digestive Diseases and Sciences. 36(9). 1197–1203. 68 indexed citations
14.
Angeli, Paolo, Angelo Gatta, Lorenza Caregaro, et al.. (1991). Hypophosphatemia and renal tubular dysfunction in alcoholics. Gastroenterology. 100(2). 502–512. 21 indexed citations
15.
Prandoni, Paolo, Mario Vigo, Anna Maria Cattelan, & A. Ruol. (1990). Treatment of Deep Venous Thrombosis by Fixed Doses of a Low-Molecular-Weight Heparin (CY216). Pathophysiology of Haemostasis and Thrombosis. 20(Suppl. 1). 220–223. 35 indexed citations
16.
Angeli, Paolo, Angelo Gatta, Lorenza Caregaro, et al.. (1990). Tubular site of renal sodium retention in ascitic liver cirrhosis evaluated by lithium clearance. European Journal of Clinical Investigation. 20(1). 111–117. 54 indexed citations
17.
Merkel, Carlo, Angelo Gatta, David Sacerdoti, et al.. (1988). Long-term effect of nadolol on quantitative liver function tests in patients with cirrhosis. European Journal of Clinical Pharmacology. 34(5). 501–504. 8 indexed citations
18.
Gatta, Angelo, Massimo Bolognesi, Carlo Merkel, et al.. (1987). Long‐term effects of beta‐adrenergic blockade with nadolol on hepatic and renal haemodynamics and function in cirrhotics. Clinical Physiology. 7(5). 377–387. 7 indexed citations
19.
Gatta, Angelo, David Sacerdoti, Carlo Merkel, et al.. (1987). Renal effects of nadolol in cirrhosis. European Journal of Clinical Pharmacology. 33(5). 473–477. 5 indexed citations
20.
Realdi, G., A. Albertí, Massimo Rugge, et al.. (1982). Long-term follow-up of acute and chronic non-A, non-B post-transfusion hepatitis: evidence of progression to liver cirrhosis.. Gut. 23(4). 270–275. 158 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026